In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension.
Clinical trials evaluating the efficacy of chronic electrical stimulation of the carotid baroreflex for the treatment of hypertension (HTN) are ongoing. However, the mechanisms by which this device lowers blood pressure (BP) are unclear, and it is uncertain which patients are most likely to receive...
Guardado en:
Autores principales: | John S Clemmer, W Andrew Pruett, Robert L Hester |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ccf075de94b44fd0b77f9215b0552cb4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension
por: John S. Clemmer, et al.
Publicado: (2021) -
Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
por: Anna Meta Dyrvig Kristensen, et al.
Publicado: (2020) -
Intracranial baroreflex is attenuated in an ovine model of renovascular hypertension
por: Sydney Vari, et al.
Publicado: (2021) -
Endovascular baroreflex amplification and the effect on sympathetic nerve activity in patients with resistant hypertension: A proof-of-principle study.
por: Monique E A M van Kleef, et al.
Publicado: (2021) -
Endovascular baroreflex amplification and the effect on sympathetic nerve activity in patients with resistant hypertension: A proof-of-principle study
por: Monique E. A. M. van Kleef, et al.
Publicado: (2021)